Defilade Capital Management

Defilade Capital Management as of June 30, 2026

Portfolio Holdings for Defilade Capital Management

Defilade Capital Management holds 39 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Eli Lilly & Co. (LLY) 6.3 $47M 39k 1199.43
Pfizer (PFE) 5.7 $43M 1.8M 24.08
Veeva Sys Cl A Com (VEEV) 5.6 $42M 237k 177.47
BioMarin Pharmaceutical (BMRN) 5.2 $39M 682k 57.22
Ptc Therapeutics I (PTCT) 4.7 $35M 434k 81.57
Baxter International (BAX) 4.2 $31M 1.5M 21.32
Insmed Com Par $.01 (INSM) 4.0 $30M 282k 106.62
Zimmer Holdings (ZBH) 3.7 $27M 317k 86.09
Insulet Corporation (PODD) 3.6 $27M 177k 152.25
Thermo Fisher Scientific (TMO) 3.5 $26M 52k 501.36
Abbott Laboratories (ABT) 3.5 $26M 286k 90.74
Ascendis Pharma A/s Ord Shs (ASND) 3.4 $25M 95k 266.72
Solventum Corp Com Shs (SOLV) 3.3 $24M 317k 77.15
Medtronic SHS (MDT) 3.2 $24M 303k 78.23
Elanco Animal Health (ELAN) 2.8 $21M 864k 24.61
Agios Pharmaceuticals (AGIO) 2.7 $20M 547k 37.11
Envista Hldgs Corp (NVST) 2.6 $19M 726k 26.35
Revolution Medicines (RVMD) 2.1 $16M 83k 187.28
ICU Medical, Incorporated (ICUI) 2.1 $16M 106k 146.60
Cogent Biosciences (COGT) 2.0 $15M 393k 38.70
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) 2.0 $15M 133k 110.94
Ocular Therapeutix (OCUL) 2.0 $15M 1.5M 9.82
Eledon Pharmaceuticals (ELDN) 1.9 $14M 3.5M 3.94
Tyra Biosciences (TYRA) 1.6 $12M 377k 31.94
Olema Pharmaceuticals (OLMA) 1.5 $12M 925k 12.51
Oric Pharmaceuticals (ORIC) 1.5 $11M 1.0M 10.83
Larimar Therapeutics (LRMR) 1.5 $11M 3.7M 3.05
Globus Med Cl A (GMED) 1.5 $11M 140k 79.01
Colfax Corp (ENOV) 1.5 $11M 532k 20.70
Evommune Com Shs (EVMN) 1.4 $11M 793k 13.29
Teleflex Incorporated (TFX) 1.4 $10M 80k 126.76
Denali Therapeutics (DNLI) 1.3 $10M 392k 25.72
Glaukos (GKOS) 1.2 $9.3M 67k 139.76
Staar Surgical Com Par $0.01 (STAA) 1.2 $9.2M 322k 28.69
Pacs Group Com Shs (PACS) 1.2 $9.2M 216k 42.64
Crinetics Pharmaceuticals In (CRNX) 1.2 $9.0M 239k 37.42
Livanova SHS (LIVN) 1.2 $8.8M 107k 82.23
Black Diamond Therapeutics (BDTX) 0.4 $3.1M 1.7M 1.85
Mereo Biopharma Group Spon Ads (MREO) 0.3 $2.4M 7.6M 0.32